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ABSTRAK
Latar belakang: kejadian acute kidney injury (AKI) di unit perawatan intensif berhubungan dengan 
peningkatan mortalitas, morbiditas pasca AKI dan biaya perawatan tinggi. Penelitian mengenai faktor-faktor 
yang berhubungan dengan mortalitas pasien AKI di unit perawatan intensif di Indonesia khususnya RSUPN dr. 
Cipto Mangungkusumo belum pernah dilakukan. Penelitian ini bertujuan untuk mengetahui prevalensi AKI, angka 
mortalitas pasien AKI, dan faktor- faktor yang berhubungan dengan peningkatan mortalitas pasien AKI di unit 
perawatan intensif di ICU RSUPN dr. Cipto Mangunkusumo. Metode: penelitian kohort retrospektif terhadap 
seluruh pasien AKI di unit perawatan intensif di RSUPN Cipto Mangunkusumo periode Januari 2015 – Desember 
2016. Dilakukan analisis hubungan bivariat sampai dengan multvariat dengan STATA Statistics 15.0 antara faktor 
usia >60 tahun, sepsis, ventilator, durasi ventilator, dialisis, oligoanuria, dan skor APACHE II saat admisi dengan 
mortalitas. Hasil: prevalensi pasien AKI di unit perawatan intensif didapatkan 12,25% (675 dari 5511 subjek) dan 
sebanyak 220 subjek (32,59%) dari 675 subjek yang dianalisis meninggal di unit perawatan intensif. Faktor-faktor 
yang berhubungan dengan peningkatan mortalitas pada analisis multivariat adalah sepsis (OR 6,174; IK95% 
3,116-12,233), oligoanuria (OR 4,173; IK95% 2,104-8,274), ventilator (OR 3,085; IK95% 1,348-7,057), (skor 
APACHE II saat admisi)1/2 [OR 1,597; IK95% 1,154-2,209], dan durasi ventilator (OR 1,062; IK95% 1,012-
1,114). Kesimpulan: prevalensi pasien AKI dan angka mortalitasnya di unit perawatan intensif RSUPN dr. Cipto 
Mangunkusumo didapatkan sebesar 12,25% dan 32,59%. Sepsis, oligoanuria, ventilator, (skor APACHE II saat 
admisi)1/2, dan durasi ventilator merupakan faktor-faktor yang berhubungan bermakna dengan peningkatan 
mortalitas pasien AKI di unit perawatan intensif.
Kata kunci: acute kidney injury, faktor risiko, mortalitas, unit perawatan intensif.
ABSTRACT
Background: the incidence of acute kidney injury (AKI) in intensive care units is associated with increased 
mortality, post AKI morbidity and high treatment costs. Research on factors related to mortality of AKI patients in 
intensive care units in Indonesia, especially Cipto Mangungkusumo General Hospital has never been done. This study 
aims to determine the prevalence of AKI, mortality rate of AKI patients, and the factors associated with increased 
Vol 51• Number 4 • October 2019                               Factors associated with mortality of ICU patients with AKI
325
mortality of AKI patients in intensive care units in ICU Cipto Mangunkusumo General Hospital. Methods: this is 
a retrospective cohort study of all patients diagnosed with AKI in the intensive care unit at Cipto Mangunkusumo 
General Hospital, January 2015 - December 2016. An analysis of bivariate relationships with multvariate with 
STATA Statistics 15.0 between age > 60 years, sepsis, use of ventilator, ventilator duration, dialysis, oligoanuria, 
and APACHE II scores at admission with mortality. Results: the prevalence of AKI patients in the intensive care 
unit was 12.25% (675 of 5511 subjects) and 220 subjects (32.59%) of the 675 analyzed subjects died in the intensive 
care unit. Factors related to increased mortality in multivariate analysis were sepsis (OR 6,174; IK95% 3,116-
12,233), oligoanuria (OR 4,173; IK95% 2,104-8,274), use of ventilator (OR 3,085; IK95% 1,348-7,057), (scores 
APACHE II at admission) 1/2 [OR 1,597; IK95% 1.154-2.209], and the duration of the ventilator (OR 1.062; 
IK95% 1.012-1.114). Conclusion: the prevalence of AKI patients and their mortality rate in the intensive care 
unit of Cipto Mangunkusumo General Hospital obtained 12.25% and 32.59%. Sepsis, oligoanuria, ventilators 
(APACHE II score at admission) 1/2, and ventilator duration are factors that are significantly associated with 
increased mortality of AKI patients in intensive care units.
Keywords: acute kidney injury, risk factors, intensive care unit, mortality.
INTRODUCTION
Acute kidney injury (AKI) is currently a 
major health problem worldwide with AKI 
incidence ranges from 20 to 200 cases per 1 
million population in community and 5.4 to 288 
cases per 100,000 population in hospital with a 
mortality rate of 1.7 million deaths per year.1 
The majority of AKI cases occur in ICU patients 
with incidence ranges from 15.8 to 65% and high 
mortality rates is also found ranging from 24 to 
64.7%.2–8 Post-AKI outcomes include increased 
risk of chronic kidney disease and end-stage renal 
disease, longer duration of hospitalization, higher 
mortality at both hospital and post-hospital care, 
as well as high costs of AKI care reaching USD$ 
1,700,000 per year in the United States.9–11
Several studies have been conducted to 
identify factors related to mortality of ICU patients 
with AKI. These factors include metabolic 
acidosis, use of mechanical ventilation, APACHE 
II score, advance AKI stage, hypotension, higher 
creatinine levels, leukocytosis, hyperkalemia 
and blood urea level at the time of diagnosis of 
AKI are the predictors of in-hospital mortality of 
ICU patients with AKI.6,8 But these risk factors 
may differ between countries, probably because 
of the difference patient characteristics (race, 
age, cause of AKI) and healthcare system where 
the study was conducted. To date, there is no 
study assessing risk factors of mortality in ICU 
patients in AKI. Based on the above mentioned 
consideration, it is necessary to conduct a study 
on factors associated with mortality of ICU 
patients with AKI. To date, no study has been 
conducted in Indonesia addressing the issue.
METHODS
A retrospective cohort study was conducted 
among adults (>18 years old) critically ill patients 
with who were treated at Cipto Mangunkusumo 
Hospital (RSCM), Jakarta, a tertiary national 
level referral hospital in Indonesia during January 
2015 to December 2016 period. Patients who had 
been previously diagnosed with Chronic Kidney 
Disease (CKD), had received routine dialysis prior 
to the study, had a kidney transplant and those who 
had been diagnosed with AKI, but subsequently 
died within <48 hours during their hospitalization 
in the ICU were excluded. Demographic, clinical 
and laboratory data were obtained from medical 
records and electronic health record (EHR). The 
diagnosis of AKI was reestablished by the authors 
using KDIGO classification. The protocol of 
the study been approved by the Research Ethics 
Committee, Faculty of Medicine, Universitas 
Indonesia/Cipto Mangunkusumo Hospital, 
reference number 434/UN2.F1/ETIK/2017 on 
May 8th, 2017.
The primary outcome was mortality rate of 
ICU patients with AKI who were hospitalized 
more than 48 hours. Subjects will be classified 
as survivor and non-survivor AKI. There were 
seven variables that had been assessed including 
patients with the age of > 60 years old, patients 
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with sepsis, patients with mechanical ventilator, 
duration of ventilator use, dialysis, oligoanuria, 
and score of Acute Physiology and Health 
Chronic Evaluation (APACHE) II at admission. 
Sepsis was assessed based on the following 
criteria i.e. the presence of clear or suspected 
focus of infection and an acute increase in SOFA 
score of ≥ 2.12 Urine production of <400 ml / 
24 hours was considered as oligouria and urine 
production of <50 ml / 24 hours was considered 
as anuria.13
Data were analyzed using STATA Statistics 
software program version 15.0. Bivariate 
analysis was utilized to observe the correlation 
between dependent and independent variables 
using Chi square statistical test for categorical 
variables, unpaired t-test for APACHE II score 
variable at admission, and Mann Whitney test for 
ventilator duration variable. Subsequently, the 
analyses of those variables were continued into 
a multivariate model when the bivariate analysis 
showed p value of <0.25. Statistically significant 
was considered when p < 0.05.
RESULTS
There were 5511 subjects aged ≥18 years 
who were admitted to the ICU between January 
2015 and December 2016. About 1349 out of 
5511 subjects who were diagnosed with AKI 
based on medical records, 674 subjects had met 
the exclusion criteria (CKD, previous history of 
renal transplantation, routine dialysis and death 
occurred within 48 hours after ICU admission); 
therefore, only 675 subjects were included in 
our study. The median age in this study was 49 
years old and the majority of subjects were male 
(63.41%); while the prevalence of AKI in ICU 
patients was 12.25% (675 out of 5511). The 
diagnosis of AKI was reestablished by the author 
and we found a discrepancy of AKI diagnosis in 
199 subjects out of 675 subjects (29.48%).
The proportions of AKI events based on 
the sites of study were 36.44% for Emergency 
Room/ ER ICU, 20.77% for ICU Center, 13.63% 
for Burn Unit ICU, 13.04% High Care Unit, 
11.26% for Intensive Coronary Care Unit/ICCU, 
3.56% for Cardiac Intensive Care Unit/CICU 
and 1.33% for the other HCU. Most patients 
(90.81%) had National Health Insurance as 
their financial support. Based on the onset, AKI 
was commonly found in most of ICUs except in 
ICCU and ER ICCU, where most of AKI had 
occurred before the patients were admitted to 
the ICU (65.79% and 53.25%).
The majority of the subjects with AKI in our 
study had received nephrotoxic drugs (97.93%) 
and mostly had taken Proton Pump Inhibitors/
PPI (68.89%), carbapenem (49.04%), and 
cephalosporin (40.89%). The mortality rate of 
patients with AKI in the ICU was 32.59% (220 
of 675 subjects) with the top three leading cause 
of death were sepsis shock (88.64%), respiratory 
failure (5.45%) and cardiovascular complications 
(4.09%). The baseline subject characteristics are 
shown in Table 1.
Bivariate and Multivariate Analyses on Risk 
Factors Associated with Mortality
Death was occurred in 220 out of 675 (32.59; 
95% CI 32.56 – 32.63). In bivariate analysis, 
there were six variables associated mortality in 
ICU patients with AKI i.e. sepsis, mechanical 
ventilator, duration of ventilator use, dialysis, 
oligoanuria, and APACHE II score at admission. 
The variables with p < 0.25 found in the bivariate 
analysis were subsequently included in the 
multivariate analysis. In multivariate analysis 
using logistic regression, we found five variables 
with p <0.05 as shown in Table 2.
DISCUSSION
The mortality rate of ICU patients with AKI 
in our study was 32.59%. The rate is lower than 
the result found in a study, which was conducted 
by Andrikos et al.3 and Wijewikamaama et 
al8; but it is similar to the result in a study 
conducted by Ralib et al14. Our results have similar 
characteristics with results demonstrated by Ralib 
et al.14 i.e. the AKI criteria were based on KDIGO 
criteria, the subjects were those who were ≥18 
years old, were hospitalized in the ICU with a 
duration of ≥48 hours, most patients were male at 
the same age with a median age of 50 years and 
sepsis was observed in 2/3 of patients with AKI.
Factors Associated With Mortality
In our study, we found that the proportion 
of patients aged > 60 years in the survivor AKI 
group and the non-survivor AKI group was not 
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Table 1. Basic subject characteristics
Variables Total AKI (n=675) Survivor AKI (n=455) Non-Survivor AKI (n=220)
Male [n(%)] 428 (63.41) 291 (63.96) 137 (62.27)
Age (y.o) [median (min-max)] 49 (18-90) 49 (18-90) 50 (18-86)
Age >60 y.o [n (%)] 147 (21.78) 97 (21.32) 50 (22.73)
Length of stay (days) [median (min-max)] 7 (1-78) 6 (1-65) 9 (1-78)
AKI onset [(n)%]
 - Pre-ICU 323 (47.85) 232 (50.99) 91  (41.36)
 - In ICU 332(52.15) 223 (49.01) 129 (58.64)
AKI severity [n (%)]
 - AKI I 487 (72.15) 357 (78.46) 130 (59.64)
 - AKI II 66 (9.78) 37 (8.13) 29 (13.18)
 - AKI III 122 (18.07) 61 (13.41) 61 (27.73)
Sepsis [(n)%] 411 (60.89) 208 (45.71) 203 (92.27)
Dialysis [(n)%] 74(10.96) 27 (5.93) 47 (21.36)
 - Intermittent hemodialysis 39 (5.78) 21 (4.62) 18  (8.18)
 - CRRT 27 (4.0) 4 (0.88) 23 (10.45)
 - Combination 8 (1.19) 2 (0.44) 6 (2.73)
Ventilator Mechanic [n (%)] 454 (67.26) 252 (55.38) 202 (91.82)
Duration of ventilator use (days)  
[median (min-max)] 2 (0-49) 1 (0-47) 7 (0-49)
Oligoanuria (n=414) [(n)%] 66 (15.94) 25 (8.50) 41 (34.17)
Urine Output (cc/kgBW/day)  
[median (min-max)] 0.985 (0-4.75) 1.01 (0-4.75) 0.73 (0-3.9)
APACHE II score at ICU admission (n=441) 
[median (min-max)] 8 (0-30) 7 (0-30) 11 (2-25)
Contrast agents [n(%)] 110 (16.30) 94 (20.66) 16 (7.27)
Surgery [n(%)] 418 (61.93) 288 (63.30) 130 (59.09)
Nephrotoxic drugs [n(%)] 661(97.93) 444 (97.58) 217 (98.64)
Vasopressors [n(%)] 377 (55.85) 175 (38.46) 202 (91.82)
Comorbidities [n(%)]
 - Diabetes Mellitus 99 (14.67) 72 (15.82) 27 (12.27)
 - Cardiovasculara 244 (36.15) 182 (40) 62 (28.18)
 - Cerebrovascularb 59 (8.74) 43 (9.45) 16 (7.27)
 - Pulmonaryc 276 (40.18) 158 (34.73) 118 (53.64)
 - Malignancy 116 (17.19) 82 (18.02) 34 (15.45)
 - Othersd 49 ((7.25) 37 (8.13) 12 (5.45)
Creatinine level (mg/dL) [median (min-max)] 1.45 (0.47-12.4) 1.4 (0.5-9.59) 1.7 (0.47-12.4)
Plasma pH [median (min-max)] 7.39 (6.96-7.67) 7.403 (7.0-7.673) 7.371 (6.96-7.66)
Bicarbonate level  (mEq/L) [median (min-max)] 21 (5-47.5) 21.2  (4.0-47.5) 20.6  (7.8–42.9)
Pottasium (mEq/L) [median (min-max)] 4.13 (2.1-7.87) 4.1 (2.1 – 7.6) 4.35 (2.3-7.87)
AKI, Acute Kidney Injury; APACHE, Acute Physiology and Chronic Health Evaluation; CRRT, Continuous Renal Replacement 
Therapy. a Including hypertension, coronary arterial disease and chronic heart failure b Including stroke, trauma, dissecting 
aneurysm, and infection, c Including pneumonia, chronic obstructive pulmonary disease, and pulmonary tuberculosis. 
dIncluding chronic liver disease, hepatitis B and C, cirrhosis hepatis, autoimmune, dan Acquired Immunodeficiency Syndrome 
(AIDS).
different. Studies by Bucuvic et al15 and Elhendy 
et al.16 have suggested that the age of > 60 years 
is a factor associated with a 3-folds higher 
mortality risk in subjects with AKI. The higher 
mortality risk is associated with renal epithelial 
cell proliferation disorder and progenitor cell as 
well as stem cell function due to aging process.15 
In contrast to the results of those studies, our 
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study showed that the age of > 60 years was 
not associated with higher mortality among 
ICU patients with AKI. It may occur since the 
median age found in our study was 49 years old 
and the proportion of patients aged > 60 years 
was 21.78%. Our findings support the result of a 
study by Lameire et al.17, which found that older 
age is not associated with higher mortality rate 
among patients with AKI.
The proportion of sepsis in ICU patients 
with AKI in our study was 60.89%. Sepsis was 
more commonly found in the non-survivor AKI 
group (92.27%). Among patients with AKI who 
developed sepsis, the proportion of co-morbid 
pulmonary disease was 51.82% (213 subjects) 
and the proportion of vasopressor drug use was 
79.94% (308 subjects); moreover, the median 
of APACHE II score at admission was 11 with 
a range between 0 and 30. Our study found 
an association between sepsis and increased 
mortality among ICU patients with AKI. Our 
findings are in consistent with the results of 
studies conducted by Elhendy et al.4, Zhou et 
al.15, and Daher et al.18 Those studies demonstrate 
that sepsis is a factor associated with increased 
mortality among ICU patients with AKI revealing 
OR of 13.75 (95%CI 1.68-112.02), OR of 4.55 
(95%CI 1.037-19.87) and OR 4.79 (95%CI 1.88-
12.17) respectively for each study.4,15,18 Sepsis 
is a life-threatening organ dysfunction due to 
dysregulation of host response to infection.12 
The release of pro-inflammatory cytokines (IL-
1, IL-6, TNF-) will lead to severe inflammatory 
reactions and multiple organ dysfunction that 
subsequently cause death.19
In our study, we found that the proportion of 
ventilator use was 67.26% among ICU patients 
with AK; while the proportion in the non-survivor 
AKI group was 91.82%. Among subjects in the 
AKI group who used mechanical ventilator, the 
proportion of pulmonary concomitant disease 
was 45.37% (206 subjects), the proportion of 
subjects with sepsis was 72.91% (331 subjects), 
the proportion of subjects using vasopressor 
drug was 69.16% (314 subjects) and the median 
APACHE II score at admission was 9. Our 
study found a significant association between 
ventilator use and increased AKI mortality in 
ICU. Similar results have also been demonstrated 
in the studies conducted by Daher et al.18, 
Medve et al.20, and Zhou et al.4, AKI can be 
induced by mechanical ventilator through 3 
mechanisms. First, the presence of hypercapnia 
or hypoxemia can suppress blood flow to the 
kidneys. Second, increased intra-thoracic and 
intra-abdominal pressure will decrease cardiac 
output and eventually decrease blood flow to the 
kidneys. Third, the mechanical ventilator causes 
an inflammatory reaction in the lung that will 
induce the release of a systemic inflammatory 
mediator.21
The median for duration of ventilator use 
in our study was 2 days; however, in the non-
survivor AKI group, the median was 7 days, 
which is longer than the median found in the 
survivor AKI group that was 1 day. Our study 
found a significant association between the 
duration of ventilator use and the increased 
mortality among ICU patients with AKI. A study 
conducted by Wang et al supports the results of 
our study. Thay found that 1 day longer duration 
of ventilator use will increase mortality by OR 
Table 2. Bivariate and multivariate analysis
Variables
Bivariate Analysis Multivariate Analysis
RR (95%CI) P OR (95%CI) P
Sepsis 7.67 (4.793-12.274) < 0.001 6.174 (3.116-12.233) < 0.001
Ventilator Mechanic 5.463 (3.468-8.606) < 0.001 3.085 (1.348-7.057) < 0.001
Duration of Ventilator use - <0.001* 1.062 (1.012-1.114) 0.015
Oligoanuria 2.736 ( 2.088-3.586) < 0.001 4.173 (2.104-8.274) < 0.001
(APACHE II score at admission)1/2** (-0.819- (-0.466)) < 0.001*** 1.597 (1.154—2.209) 0.005
Dialysis 2.206 (1.782-2.732) < 0.001 1.034 (0.419-2.555) 0.942
APACHE, Acute Physiology and Chronic Health Evaluation. * Mann Whitney test. ** Normalization with squareroot.
** Unpaired t-test
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of 1.08 (95%CI 1.008-1.158).22 Longer duration 
of mechanical ventilator use will increase the 
risk of infection and mortality.22 AKI alone may 
prolong the duration of mechanical ventilator 
use; thus further triggering trauma to the lungs 
and difficult extubating.23,24
The proportion of dialysis in our study 
was 10.96%. The proportion of AKI subjects 
undergoing dialysis was more commonly found in 
the non-survivor group than in the survivor group 
(21.36% vs. 5.93%). Based on the degree of AKI 
in the non-survivor AKI group, we found that the 
proportion of subjects using dialysis was 29.79% 
in AKI I, 19.15% in AKI II and 51.06% in AKI III. 
In our study, the bivariate analysis demonstrated 
a significant association between dialysis and 
increased mortality among ICU patients with 
AKI (RR 2.206; 95%CI 1.782-2.732). However, 
the multivariate analysis found no significant 
association with OR 1.034 (95%CI 0.419-2.555). 
In this study, dialysis served as a therapeutic factor 
in AKI; moreover, the proportion of AKI severity 
in this study was dominated by AKI I (72.15%). 
Dela Cruz et al.24 have also found a meaningless 
association between dialysis and increased 
mortality among ICU patients with AKI using the 
bivariate analysis.
Our study found that the proportion of 
oligoanuria was 15.94%. The proportion of AKI 
subjects with oligoanuria was more common 
in the non-survivor AKI group (34.17%) than 
the survivor AKI group (8.5%). Based on the 
severity of AKI in the non-survivor AKI group, 
the proportion of oligoanuria was 39.02% in 
AKI I, 19.51% in AKI II, and 41.46% in AKI 
III. We found that the more severe the severity of 
AKI, the greater the proportion of subjects with 
oligoanuria. Our study also found a significant 
association between oligoanuria and increased 
mortality among ICU patients with AKI. The 
findings are supported by studies conducted by 
Elhendy et al.15 (OR of 9.4 [95%CI 1.909-46.27])
and Daher et al.18 (OR 5.59 [95%CI 1.83-17.07]).
Patients with AKI who had oligoanuria had 
worse prognosis than those with non-oligouria 
AKI. Two possible underlying mechanisms 
are (1) the degree of severity of parenchymal 
structural changes is found to be greater in the 
oligoanuria AKI and (2) oligoanuria is more 
common in multiple organ failure conditions 
and critical illnesses that underlie the occurrence 
of AKI.25 The median APACHE II score at 
admission in our study was 8. The score was 
greater in the non-survivor AKI group compared 
to the score in survivor AKI group (11 vs. 7). 
Based on the degree of AKI severity in the non-
survivor AKI group, the median APACHE II 
score at admission was 9.5 in AKI I, 13 in AKI 
II, and 13.5 in AKI III.
The above mentioned results show that the 
non-survivor AKI group had a greater degree of 
disease severity. Furthermore, the more severe 
the severity of AKI, the greater the median 
APACHE II score at admission. In our study we 
found a significant correlation between APACHE 
II score at admission and increased mortality 
among ICU patients with AKI. Our findings are 
supported by results of studies conducted by 
Wang et al and Daher et al, that show similar 
results with OR 1.072 (95%CI 1.037-1.109) and 
OR 1.14 (95%CI 1.05-1.23), respectively.18,22
Our study is the first study conducted in 
Indonesia on factors associated with mortality 
among ICU patients with AKI. Unlike the 
previous studies, we involved subjects with a 
variety of characteristics including medical and 
surgical history including burns, acute heart 
disease and trauma. At last, the diagnosis of AKI 
is re-established and we found a discrepancy of 
AKI diagnosis as much as 29.48%.
Our study has several limitations. First, 
it was retrospective, in which the data were 
obtained from medical records and EHR system 
at Cipto Mangunkusumo National Central 
General Hospital and therefore, there were some 
incomplete data (oligoanuria, APACHE II score 
at admission, blood gas analysis, potassium 
serum level); however, those did not affect the 
results of our study. Second, the exclusion of 
CKD was performed based on supporting data 
(renal ultrasound and plasma creatinine level), 
which were obtained from medical records and 
EHR system at Cipto Mangunkusumo National 
Central General Hospital.
CONCLUSION
The prevalence of AKI in ICU patients at 
Cipto Mangunkusumo National Central General 
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Hospital was not high; however, the mortality 
rate of ICU patients with AKI was high. Sepsis, 
oligoanuria, ventilator, APACHE II score at 
admission and duration of ventilator use were 
significantly associated with increased mortality 
rate among ICU patients with AKI at Cipto 
Mangunkusumo Hospital.
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